274 An analysis of mutations from over 7,000 cancers of diverse origins reveals the diversity of mutational processes underlying the development of cancer.
http://www.nature.com/nature/journal/v500/n7463/full/nature12477.html
273 Hydrophobic Anticancer Drug Delivery by a 980 nm Laser-Driven Photothermal Vehicle for Efficient Synergistic Therapy of Cancer Cells In Vivo.
http://onlinelibrary.wiley.com/doi/10.1002/adma.201301232/abstract
272 Fluorescent Multiblock π-Conjugated Polymer Nanoparticles for In Vivo Tumor Targeting.
http://onlinelibrary.wiley.com/doi/10.1002/adma.201301656/abstract
271 Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes.
http://www.pnas.org/content/110/34/13809.abstract
270 Hybrid Melittin Cytolytic Peptide-Driven Ultrasmall Lipid Nanoparticles Block Melanoma Growth in Vivo.
http://pubs.acs.org/doi/abs/10.1021/nn400683s
269 Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors.
http://stke.sciencemag.org/cgi/content/abstract/sigtrans;6/288/ra68
268 Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation.
http://www.pnas.org/content/110/33/13576.abstract
267 Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy.
http://www.cell.com/cancer-cell/abstract/S1535-6108(13)00234-1
266 Directed Phenotype Switching as an Effective Antimelanoma Strategy.
http://www.cell.com/cancer-cell/abstract/S1535-6108(13)00236-5
265 Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.
http://jem.rupress.org/content/210/8/1509.abstract
264 Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.
http://www.pnas.org/content/110/32/E2987.abstract
263 Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.
http://www.pnas.org/content/110/32/13085.abstract
262 Effect of Acute Exercise on Prostate Cancer Cell Growth.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067579
261 An alternative translation start site produces an elongated PTEN that can enter tumor cells and kill them.
http://www.sciencemag.org/content/341/6144/399.abstract
260 RGD-Modified Apoferritin Nanoparticles for Efficient Drug Delivery to Tumors.
http://pubs.acs.org/doi/abs/10.1021/nn305791q
259 A mass spectrometric approach was developed for intraoperative identification of cancerous tissue, in near–real-time.
http://stm.sciencemag.org/content/5/194/194ra93.abstract
258 High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat.
http://www.nature.com/nature/journal/v499/n7458/full/nature12234.html
257 Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model.
http://www.pnas.org/content/110/29/12006.abstract
256 Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers.
http://www.pnas.org/content/110/29/11988.abstract
255 Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue.
http://www.pnas.org/content/110/29/11982.abstract
|
